97 related articles for article (PubMed ID: 30088402)
1. [Risk Factors and Preventive Effects of Laser Panretinal Photocoagulation for Neovascular Glaucoma after Ophthalmic Stereotactic Radiotherapy].
Ueda E; Yoshikawa H; Arakawa S; Kohno RI; Ohga S; Nakamura K; Ishibashi T; Sonoda KH
Nippon Ganka Gakkai Zasshi; 2016 Oct; 120(10):689-95. PubMed ID: 30088402
[TBL] [Abstract][Full Text] [Related]
2. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
4. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.
Wittström E; Holmberg H; Hvarfner C; Andréasson S
Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma.
Mahdy RA; Nada WM; Fawzy KM; Alnashar HY; Almosalamy SM
J Glaucoma; 2013 Dec; 22(9):768-72. PubMed ID: 22790513
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
10. Iris Thickness and Severity of Neovascular Glaucoma Determined Using Swept-Source Anterior-segment Optical Coherence Tomography.
Nakakura S; Kobayashi Y; Matsuya K; Terao E; Kiuchi Y
J Glaucoma; 2018 May; 27(5):415-420. PubMed ID: 29485476
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.
Hirasawa N; Tsuji H; Ishikawa H; Koyama-Ito H; Kamada T; Mizoe JE; Ito Y; Naganawa S; Ohnishi Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):538-43. PubMed ID: 17141971
[TBL] [Abstract][Full Text] [Related]
12. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
Wasik A; Song HF; Grimes A; Engelke C; Thomas A
Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparative study on neovascular glaucoma and non-neovascular refractory glaucoma following Ahmed glaucoma valve implantation.
Li Z; Zhou M; Wang W; Huang W; Chen S; Li X; Gao X; Zhang X
Chin Med J (Engl); 2014; 127(8):1417-22. PubMed ID: 24762581
[TBL] [Abstract][Full Text] [Related]
15. Neovascular glaucoma developing after uncomplicated cataract surgery for heavily irradiated eyes.
Kwok SK; Leung SF; Ho PC; Gandhi S; Chen IN; Michon JJ; Lam DS; Lai JS
Ophthalmology; 1997 Jul; 104(7):1112-5. PubMed ID: 9224462
[TBL] [Abstract][Full Text] [Related]
16. Case-matched comparison of vitrectomy, peripheral retinal endolaser, and endocyclophotocoagulation versus standard care in neovascular glaucoma.
Marra KV; Wagley S; Omar A; Kinoshita T; Kovacs KD; Silva P; Kuperwaser MC; Arroyo JG
Retina; 2015 Jun; 35(6):1072-83. PubMed ID: 25621944
[TBL] [Abstract][Full Text] [Related]
17. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
19. Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
Cassoux N; Cayette S; Plancher C; Lumbroso-Le Rouic L; Levy-Gabriel C; Asselain B; Sastre X; Couturier J; Arrufat S; Piperno-Neumann S; Dendale R; Lehoang P; Desjardins L
Retina; 2013; 33(7):1441-7. PubMed ID: 23514798
[TBL] [Abstract][Full Text] [Related]
20. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
